受强制性开放获取政策约束的文章 - Mark Russo了解详情
无法在其他位置公开访问的文章：7 篇
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma
C Wald, MW Russo, JK Heimbach, HK Hussain, EA Pomfret, J Bruix
Radiology 266 (2), 376-382, 2013
强制性开放获取政策： US National Institutes of Health
Drug-induced liver injury with autoimmune features
AS deLemos, DM Foureau, C Jacobs, W Ahrens, MW Russo, ...
Seminars in liver disease 34 (02), 194-204, 2014
强制性开放获取政策： US National Institutes of Health
Hepatocellular carcinoma and cholangiocarcinoma: an update
C Yazici, DJ Niemeyer, DA Iannitti, MW Russo
Expert review of gastroenterology & hepatology 8 (1), 63-82, 2014
强制性开放获取政策： US National Institutes of Health
miR‐122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA
H Sendi, M Mehrab‐Mohseni, DM Foureau, S Ghosh, TL Walling, ...
Liver International 35 (4), 1315-1323, 2015
强制性开放获取政策： US National Institutes of Health
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient
VC Maddukuri, MW Russo, WA Ahrens, SU Emerson, RE Engle, ...
Digestive diseases and sciences 58, 2413-2416, 2013
强制性开放获取政策： US National Institutes of Health
Predictive accuracy of quick sequential organ failure assessment for hospital mortality decreases with increasing comorbidity burden among patients admitted for suspected infection
SP Taylor, A McWilliams, BT Taylor, AC Heffner, SH Chou, M Runyon, ...
Critical Care Medicine 47 (8), 1081-1088, 2019
强制性开放获取政策： US National Institutes of Health, Patient-Centered Outcomes Research Institute
MIRNA 19B: NOVEL BIOMARKER AND INHIBITOR OF HEPATIC STELLATE CELL-MEDIATED FIBROGENESIS: 788
AM Lakner, TL Walling, N Steuerwald, IH McKillop, MW Russo, ...
Hepatology 54 (4), 734A-735A, 2011
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：22 篇
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study
N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, ...
Gastroenterology 148 (7), 1340-1352. e7, 2015
强制性开放获取政策： US National Institutes of Health
Clinical best practice advice for hepatology and liver transplant providers during the COVID‐19 pandemic: AASLD expert panel consensus statement
OK Fix, B Hameed, RJ Fontana, RM Kwok, BM McGuire, DC Mulligan, ...
Hepatology 72 (1), 287-304, 2020
强制性开放获取政策： US National Institutes of Health
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
EA Pomfret, K Washburn, C Wald, MA Nalesnik, D Douglas, M Russo, ...
Liver Transplantation 16 (3), 262-278, 2010
强制性开放获取政策： US National Institutes of Health
Spectrum of statin hepatotoxicity: experience of the drug‐induced liver injury network
MW Russo, JH Hoofnagle, J Gu, RJ Fontana, H Barnhart, DE Kleiner, ...
Hepatology 60 (2), 679-686, 2014
强制性开放获取政策： US National Institutes of Health
Inhibitory effects of microRNA 19b in hepatic stellate cell‐mediated fibrogenesis
AM Lakner, NM Steuerwald, TL Walling, S Ghosh, T Li, IH McKillop, ...
Hepatology 56 (1), 300-310, 2012
强制性开放获取政策： US National Institutes of Health
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
AH Harrill, PB Watkins, S Su, PK Ross, DE Harbourt, IM Stylianou, ...
Genome research 19 (9), 1507-1515, 2009
强制性开放获取政策： US National Institutes of Health
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements
HL Bonkovsky, DE Kleiner, J Gu, JA Odin, MW Russo, VM Navarro, ...
Hepatology 65 (4), 1267-1277, 2017
强制性开放获取政策： US National Institutes of Health
American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease
OK Fix, EA Blumberg, KM Chang, J Chu, RT Chung, EK Goacher, ...
Hepatology 74 (2), 1049-1064, 2021
强制性开放获取政策： US National Institutes of Health
Liver injury from nonsteroidal anti‐inflammatory drugs in the United States
PA Schmeltzer, AS Kosinski, DE Kleiner, JH Hoofnagle, A Stolz, ...
Liver international 36 (4), 603-609, 2016
强制性开放获取政策： US National Institutes of Health
Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation
RD Fannin, M Russo, TM O'Connell, K Gerrish, JH Winnike, J Macdonald, ...
Hepatology 51 (1), 227-236, 2010
强制性开放获取政策： US National Institutes of Health
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection—a randomized trial
F Poordad, E Lawitz, KR Reddy, NH Afdhal, C Hézode, S Zeuzem, ...
Gastroenterology 145 (5), 1035-1044. e5, 2013
强制性开放获取政策： US National Institutes of Health
Effect of a multicomponent sepsis transition and recovery program on mortality and readmissions after sepsis: the improving morbidity during post-acute care transitions for …
SP Taylor, S Murphy, A Rios, A McWilliams, L McCurdy, SH Chou, ...
Critical care medicine 50 (3), 469-479, 2022
强制性开放获取政策： US National Institutes of Health, Patient-Centered Outcomes Research Institute
Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance
MW Russo, N Steuerwald, HJ Norton, WE Anderson, D Foureau, ...
Liver international 37 (5), 757-764, 2017
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定